Qualification verification expands into education and admissions

Beginning November 20, colleges of pharmacy will be required to undergo curriculum evaluation and accreditation, and if they fail to meet the standards, they may be blocked from admitting new students. As quality control mechanisms that had previously been applied to other medical fields are extended to pharmacy education, a structure is being created in which the educational environment and operational standards of pharmacy schools are directly compared at the admissions stage.

This change is not merely a tightening of administrative procedures, but is closer to a public inspection of the credibility of education before student selection. For applicants, it means more information for judging which school to choose, while for universities, the burden grows to align academic operations, facilities, and outcomes with actual standards.

Standardization pressure on herbal medicine production and research

In the field of herbal and crude drug preparations, the definition of standard decoctions has been revised so that not only traditional extraction methods but also the use of modern equipment is brought within the institutional framework. In addition, the advancement of the Korean Medicine Laboratory Information Management System (KLIMS) is expanding the foundation for the automatic collection and analysis of research data. In both manufacturing and research settings, the trend is toward reducing operations centered on experience and convention and moving to systems that can be explained through reproducible data and documentation.

Behind the growing demand for this kind of standardization are cases that have damaged trust, such as the controversy over illegal advance preparation, in which customized prescriptions were advertised but mass pre-preparation was actually carried out. In the end, the system is no longer focused simply on making herbal medicine easier to produce, but is moving toward making it possible to trace how it was made and whether its claimed customization was genuine.

Greater accountability in billing and prescribing

Medical fees for Korean medicine physical therapies covered by auto insurance have increased by more than twofold over the past five years, and as indications emerged that claims were submitted for more sessions than were actually provided, the precision of cost review has become a new issue. At the same time, in a dispute in which a hepatitis B patient’s condition worsened after stopping previously prescribed medication, a settlement of 20 million won in compensation for emotional distress was reached on the grounds that explanation and follow-up observation had been insufficient, showing that record-keeping and the duty to explain are being treated more seriously in Korean medicine care as well.

These two issues may appear different in nature, but they share a common point: more than the treatment act itself, the key question became how demonstrably the process was documented. This means that as Korean medicine services expand, claims of treatment effectiveness alone are no longer enough, and the field has entered a stage in which the validity of billing and support for patient decision-making must also be verified.

Support and expansion also require proof of results

Local governments are expanding Korean medicine services into the welfare sector by supporting up to 1.8 million won in Korean medicine treatment for couples experiencing infertility or by providing customized herbal medicine to 40 low-income elderly people. These programs have the advantage of improving access and reducing cost burdens, but because public funds are being投入, they are increasingly being asked to establish clearer standards for selecting recipients and evaluating effectiveness.

Ultimately, the recent trend shows that Korean medicine and pharmacy are undergoing growth and expansion at the same time that verification mechanisms are becoming denser in proportion. As incorporation into the institutional system broadens, it becomes harder to emphasize only on-site autonomy, and an environment is taking hold in which trust must be proven through numbers and records across education, manufacturing, treatment, and welfare.